prégabaline 25

Phase III trial Pregabalin in the prevention & reduction of PreOx

la description:
ASCO 2015: Daniel Ciampi de Andrade discusses a phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx).\n\nFor more oncology news, education, and information, please visit

You may also like...

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *